Olaparib monotherapy as primary treatment in unselected triple negative breast cancer.
Ann Oncol. 2021 Feb;32(2):240-249. doi: 10.1016/j.annonc.2020.11.009. Epub 2020 Nov 24.
Ann Oncol. 2021.
PMID: 33242536
Free article.
Clinical Trial.